{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T16:39:11Z","timestamp":1794847151928,"version":"4.9.1"},"posted":{"date-parts":[[2026,6,1]]},"group-title":"In Review","reference-count":44,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,3,26]]},"abstract":"<title>Abstract<\/title>\n                <p>Background\n This study characterized a swine model of fentanyl- and heroin-induced non-lethal apnea to support development of translational strategies for opioid overdose interventions.\nMethods\n Spontaneously breathing, isoflurane-anesthetized Hanford swine (n\u2009=\u200918; 4\u201325 kg) received intravenous fentanyl (n\u2009=\u200912) or heroin (n\u2009=\u20096) via constant rate infusion (fentanyl: 30 \u00b5g\/kg\/h; heroin: 1 mg\/kg\/h) until production of respiratory arrest (i.e., apnea), defined as the absence of spontaneous breaths for two consecutive minutes. Fentanyl-treated pigs were either sexually immature (~\u20092 months) or mature (~\u20094 months); heroin-treated pigs were immature; both groups included equal numbers of males and females.\nResults\n Results are presented as median (IQR) or mean\u2009\u00b1\u2009SEM. Immature pigs required higher fentanyl doses to induce apnea compared with mature pigs, 17 (15\u201336) \u00b5g\/kg vs 8 (7\u201310) \u00b5g\/kg respectively, despite similar serum fentanyl concentration at apnea, which were 4 (3\u20137) and 6 (4\u20138) ng\/mL respectively, consistent with a significantly faster clearance in immature pigs. No significant age-related differences were observed in norfentanyl concentrations or in its pharmacokinetic parameters. Heroin infusion resulted in apnea at 360 (290\u2013502) \u00b5g\/kg. Although serum heroin concentrations remained below the LLOQ throughout all time points, its metabolites 6-acetylmorphine (6-AM) and morphine serum concentration at apnea were 57 (44\u201391) and 34 (29\u201361) ng\/mL, with 6-AM displaying faster clearance and a shorter half-life than morphine. Latency to resume spontaneous breathing was longer in immature than mature pigs that received fentanyl, and pigs exposed to heroin exhibited more severe respiratory depression, characterized by prolonged apnea and delayed or incomplete recovery, with a reduced response to naloxone compared with fentanyl. No statistically significant differences were detected between male and female pigs.\nConclusion\n In conclusion, this reproducible model enables evaluation of opioid-induced respiratory depression and its pathophysiological consequences, supporting targeted therapeutic development.<\/p>","DOI":"10.21203\/rs.3.rs-9228632\/v1","type":"posted-content","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:17:57Z","timestamp":1780337877000},"source":"Crossref","is-referenced-by-count":0,"title":["Novel Swine Model of Respiratory Depression Induced by Fentanyl and Heroin Overdose"],"prefix":"10.21203","author":[{"given":"Eduardo","family":"Hatschbach","sequence":"first","affiliation":[{"name":"University of Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Raleigh","sequence":"additional","affiliation":[{"name":"University of Minnesota Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Vigliaturo","sequence":"additional","affiliation":[{"name":"University of Minnesota Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin","family":"Hicks","sequence":"additional","affiliation":[{"name":"University of Washington School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly","family":"Baehr","sequence":"additional","affiliation":[{"name":"University of Minnesota Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra D.","family":"Comer","sequence":"additional","affiliation":[{"name":"Columbia University Irving Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Pravetoni","sequence":"additional","affiliation":[{"name":"University of Washington School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alonso G. P.","family":"Guedes","sequence":"additional","affiliation":[{"name":"University of Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/jamainternmed.2023.7282","article-title":"Caring for hospitalized adults with opioid use disorder in the era of fentanyl: a review","volume":"184","author":"Englander H","year":"2024","unstructured":"Englander H, et al. Caring for hospitalized adults with opioid use disorder in the era of fentanyl: a review. JAMA Intern Med. 2024;184:691\u2013701.","journal-title":"JAMA Intern Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","article-title":"Trends and geographic patterns in drug and synthetic opioid overdose deaths \u2013 United States, 2013\u20132019","volume":"70","author":"Mattson CL","year":"2021","unstructured":"Mattson CL, et al. Trends and geographic patterns in drug and synthetic opioid overdose deaths \u2013 United States, 2013\u20132019. MMWR Morb Mortal Wkly Rep. 2021;70:202\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"L267","DOI":"10.1152\/ajplung.00314.2024","article-title":"Opioid-induced respiratory depression: clinical aspects and pathophysiology of the respiratory network effects","volume":"328","author":"Baldo BA","year":"2025","unstructured":"Baldo BA. Opioid-induced respiratory depression: clinical aspects and pathophysiology of the respiratory network effects. Am J Physiol Lung Cell Mol Physiol. 2025;328:L267\u201389.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/bph.15580","article-title":"Understanding and countering opioid-induced respiratory depression","volume":"180","author":"Bateman JT","year":"2023","unstructured":"Bateman JT, Saunders SE, Levitt ES. Understanding and countering opioid-induced respiratory depression. Br J Pharmacol. 2023;180:813\u201328.","journal-title":"Br J Pharmacol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1366186","DOI":"10.3389\/fpsyt.2024.1366186","article-title":"Evaluating the rate of reversal of fentanyl-induced respiratory depression using a novel long-acting naloxone nanoparticle, cNLX-NP","volume":"15","author":"Averick SE","year":"2024","unstructured":"Averick SE, et al. Evaluating the rate of reversal of fentanyl-induced respiratory depression using a novel long-acting naloxone nanoparticle, cNLX-NP. Front Psychiatry. 2024;15:1366186.","journal-title":"Front Psychiatry"},{"key":"ref6","first-page":"255","article-title":"Assessment of the antinociceptive, respiratory-depressant, and reinforcing effects of the low pK(a) fluorinated fentanyl analogs, FF3 and NFEPP","author":"Edwards SR","year":"2024","unstructured":"Edwards SR et al. Assessment of the antinociceptive, respiratory-depressant, and reinforcing effects of the low pK(a) fluorinated fentanyl analogs, FF3 and NFEPP. Neuropharmacology. 2024;255.","journal-title":"Neuropharmacology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"103467","DOI":"10.1016\/j.drugpo.2021.103467","article-title":"Consuming illicit opioids during a drug overdose epidemic: illicit fentanyls, drug discernment, and the radical transformation of the illicit opioid market","volume":"99","author":"Duhart Clarke SE","year":"2022","unstructured":"Duhart Clarke SE, Kral AH, Zibbell JE. Consuming illicit opioids during a drug overdose epidemic: illicit fentanyls, drug discernment, and the radical transformation of the illicit opioid market. Int J Drug Policy. 2022;99:103467.","journal-title":"Int J Drug Policy"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/papr.12232","article-title":"Association between human pain-related genotypes and variability in opioid analgesia: an updated review","volume":"15","author":"Nielsen LM","year":"2015","unstructured":"Nielsen LM, et al. Association between human pain-related genotypes and variability in opioid analgesia: an updated review. Pain Pract. 2015;15:580\u201394.","journal-title":"Pain Pract"},{"key":"ref9","author":"Smith HS","year":"2009","unstructured":"Smith HS. Opioid metabolism. Mayo Clin Proc. 2009;84:613\u2013624."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1346109","DOI":"10.3389\/fpubh.2024.1346109","article-title":"Fact vs. fiction: naloxone in the treatment of opioid-induced respiratory depression in the current era of synthetic opioids","volume":"12","author":"Dahan A","year":"2024","unstructured":"Dahan A, et al. Fact vs. fiction: naloxone in the treatment of opioid-induced respiratory depression in the current era of synthetic opioids. Front Public Health. 2024;12:1346109.","journal-title":"Front Public Health"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1124\/jpet.122.001476","article-title":"Heroin- and fentanyl-induced respiratory depression in a rat plethysmography model: potency, tolerance, and sex differences","volume":"385","author":"Marchette RCN","year":"2023","unstructured":"Marchette RCN, et al. Heroin- and fentanyl-induced respiratory depression in a rat plethysmography model: potency, tolerance, and sex differences. J Pharmacol Exp Ther. 2023;385:117\u201334.","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"ref12","first-page":"821","article-title":"Serotonin therapies for opioid-induced dysphagia and respiratory depression: sex differences in a rat electromyography model","volume":"136","author":"Frazure M","year":"2023","unstructured":"Frazure M, et al. Serotonin therapies for opioid-induced dysphagia and respiratory depression: sex differences in a rat electromyography model. bioRxiv. 2023;136(4):821\u201343.","journal-title":"bioRxiv"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e13134","DOI":"10.1002\/emp2.13134","article-title":"Acute opioid overdose in pediatric patients","volume":"5","author":"Sandelich S","year":"2024","unstructured":"Sandelich S, et al. Acute opioid overdose in pediatric patients. J Am Coll Emerg Physicians Open. 2024;5:e13134.","journal-title":"J Am Coll Emerg Physicians Open"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJMc2313270","article-title":"Increasing exposure of young children to illicit fentanyl in the United States","volume":"390","author":"Temple C","year":"2024","unstructured":"Temple C, Hendrickson RG. Increasing exposure of young children to illicit fentanyl in the United States. N Engl J Med. 2024;390:956\u20137.","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/jamapediatrics.2023.0793","article-title":"National trends in pediatric deaths from fentanyl, 1999\u20132021","volume":"177","author":"Gaither JR","year":"2023","unstructured":"Gaither JR. National trends in pediatric deaths from fentanyl, 1999\u20132021. JAMA Pediatr. 2023;177:733\u20135.","journal-title":"JAMA Pediatr"},{"key":"ref16","article-title":"Heroin overdose-related child and adolescent hospitalizations: insight on comorbid psychiatric and substance use disorders","volume":"9","author":"Queeneth U","year":"2019","unstructured":"Queeneth U et al. Heroin overdose-related child and adolescent hospitalizations: insight on comorbid psychiatric and substance use disorders. Behav Sci (Basel). 2019;9: [page missing].","journal-title":"Behav Sci (Basel)"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/jvp.12163","article-title":"Impact of age on hepatic cytochrome P450 of domestic male Camborough-29 pigs","volume":"38","author":"Hu SX","year":"2015","unstructured":"Hu SX. Impact of age on hepatic cytochrome P450 of domestic male Camborough-29 pigs. J Vet Pharmacol Ther. 2015;38(2):150\u20139.","journal-title":"J Vet Pharmacol Ther"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1744-8069-8-38","article-title":"Molecular and cellular mechanisms of the age-dependency of opioid analgesia and tolerance","volume":"8","author":"Zhao J","year":"2012","unstructured":"Zhao J, Xin X, Xie GX, Palmer PP, Huang YG. Molecular and cellular mechanisms of the age-dependency of opioid analgesia and tolerance. Mol Pain. 2012;8:38.","journal-title":"Mol Pain"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1080\/08897077.2021.2010252","article-title":"The need for multiple naloxone administrations for opioid overdose reversals: a review of the literature","volume":"43","author":"Abdelal R","year":"2022","unstructured":"Abdelal R, Banerjee AR, Carlberg-Racich S, Darwaza N, Ito D, Epstein J. The need for multiple naloxone administrations for opioid overdose reversals: a review of the literature. Subst Abus. 2022;43:774\u201384.","journal-title":"Subst Abus"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/ALN.0000000000004622","article-title":"Opioid overdose: limitations in naloxone reversal of respiratory depression and prevention of cardiac arrest","volume":"139","author":"Lemmen M","year":"2023","unstructured":"van Lemmen M, et al. Opioid overdose: limitations in naloxone reversal of respiratory depression and prevention of cardiac arrest. Anesthesiology. 2023;139(3):342\u201353.","journal-title":"Anesthesiology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/ALN.0000000000004096","article-title":"Advances in reversal strategies of opioid-induced respiratory toxicity","volume":"136","author":"Schrier R","year":"2022","unstructured":"van der Schrier R, et al. Advances in reversal strategies of opioid-induced respiratory toxicity. Anesthesiology. 2022;136:618\u201332.","journal-title":"Anesthesiology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/13543784.2023.2187286","article-title":"The potential role of opioid vaccines and monoclonal antibodies in the opioid overdose crisis","volume":"32","author":"Martinez S","year":"2023","unstructured":"Martinez S, et al. The potential role of opioid vaccines and monoclonal antibodies in the opioid overdose crisis. Expert Opin Investig Drugs. 2023;32:181\u20135.","journal-title":"Expert Opin Investig Drugs"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41541-023-00697-9","article-title":"A TLR7\/8 agonist increases efficacy of anti-fentanyl vaccines in rodent and porcine models","volume":"8","author":"Crouse B","year":"2023","unstructured":"Crouse B, et al. A TLR7\/8 agonist increases efficacy of anti-fentanyl vaccines in rodent and porcine models. NPJ Vaccines. 2023;8:107.","journal-title":"NPJ Vaccines"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"107662","DOI":"10.1016\/j.neuropharm.2019.06.001","article-title":"Development of vaccines to treat opioid use disorders and reduce incidence of overdose","volume":"158","author":"Pravetoni M","year":"2019","unstructured":"Pravetoni M, Comer SD. Development of vaccines to treat opioid use disorders and reduce incidence of overdose. Neuropharmacology. 2019;158:107662.","journal-title":"Neuropharmacology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1177\/0192623315613337","article-title":"Miniature swine breeds in toxicology and drug safety assessments: what to expect during clinical and pathology evaluations","volume":"44","author":"Stricker-Krongrad A","year":"2016","unstructured":"Stricker-Krongrad A, et al. Miniature swine breeds in toxicology and drug safety assessments: what to expect during clinical and pathology evaluations. Toxicol Pathol. 2016;44:421\u20137.","journal-title":"Toxicol Pathol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/0192623315618292","article-title":"Miniature swine for preclinical modeling of complexities of human disease for translational scientific discovery and accelerated development of therapies and medical devices","volume":"44","author":"Schomberg DT","year":"2016","unstructured":"Schomberg DT, et al. Miniature swine for preclinical modeling of complexities of human disease for translational scientific discovery and accelerated development of therapies and medical devices. Toxicol Pathol. 2016;44:299\u2013314.","journal-title":"Toxicol Pathol"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/0300985811402846","article-title":"Swine as models in biomedical research and toxicology testing","volume":"49","author":"Swindle MM","year":"2012","unstructured":"Swindle MM, Makin A, Herron AJ, Clubb FJ Jr, Frazier KS. Swine as models in biomedical research and toxicology testing. Vet Pathol. 2012;49(2):344\u201356.","journal-title":"Vet Pathol"},{"issue":"11","key":"ref28","doi-asserted-by":"crossref","first-page":"103743","DOI":"10.1016\/j.jpet.2025.103743","article-title":"An antifentanyl monoclonal antibody reverses fentanyl-induced apnea in pigs","volume":"392","author":"Baehr C","year":"2025","unstructured":"Baehr C, et al. An antifentanyl monoclonal antibody reverses fentanyl-induced apnea in pigs. J Pharmacol Exp Ther. 2025;392(11):103743.","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/anae.14565","article-title":"Uses and mechanisms of apnoeic oxygenation: a narrative review","volume":"74","author":"Lyons C","year":"2019","unstructured":"Lyons C, Callaghan M. Uses and mechanisms of apnoeic oxygenation: a narrative review. Anaesthesia. 2019;74(4):497\u2013507.","journal-title":"Anaesthesia"},{"key":"ref30","author":"Ayuso M","year":"2020","unstructured":"Ayuso M et al. The neonatal and juvenile pig in pediatric drug discovery and development. Pharmaceutics. 2020;13: [page missing]."},{"key":"ref31","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.theriogenology.2019.01.040","article-title":"Sexual precocity in male microminipigs evaluated immunohistologically using spermatogonial stem cell markers","volume":"130","author":"Almunia J","year":"2019","unstructured":"Almunia J, et al. Sexual precocity in male microminipigs evaluated immunohistologically using spermatogonial stem cell markers. Theriogenology. 2019;130:120\u20134.","journal-title":"Theriogenology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1177\/0192623315621413","article-title":"Sexual maturation in the female Gottingen minipig","volume":"44","author":"Peter B","year":"2016","unstructured":"Peter B, De Rijk EP, Zeltner A, Emmen HH. Sexual maturation in the female Gottingen minipig. Toxicol Pathol. 2016;44:482\u20135.","journal-title":"Toxicol Pathol"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/BF03015333","article-title":"Plasma concentrations of fentanyl in infants, children and adults","volume":"34","author":"Singleton MA","year":"1987","unstructured":"Singleton MA, Rosen JI, Fisher DM. Plasma concentrations of fentanyl in infants, children and adults. Can J Anaesth. 1987;34(2):152\u20135.","journal-title":"Can J Anaesth"},{"issue":"1","key":"ref34","first-page":"21","article-title":"Anatomic Peculiarities of Pig and Human Liver","volume":"15","author":"Nykonenko A","year":"2017","unstructured":"Nykonenko A, Vavra P, Zonca P. Anatomic Peculiarities of Pig and Human Liver. Exp Clin Transpl. 2017;15(1):21\u20136.","journal-title":"Exp Clin Transpl"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41398-023-02406-5","article-title":"Heroin and its metabolites: relevance to heroin use disorder","volume":"13","author":"Milella MS","year":"2023","unstructured":"Milella MS, et al. Heroin and its metabolites: relevance to heroin use disorder. Transl Psychiatry. 2023;13:120.","journal-title":"Transl Psychiatry"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jpba.2012.10.033","article-title":"Stability of heroin, 6-monoacetylmorphine, and morphine in biological samples and validation of an LC-MS assay for delayed analyses of pharmacokinetic samples in rats","volume":"74","author":"Jones JM","year":"2013","unstructured":"Jones JM, et al. Stability of heroin, 6-monoacetylmorphine, and morphine in biological samples and validation of an LC-MS assay for delayed analyses of pharmacokinetic samples in rats. J Pharm Biomed Anal. 2013;74:291\u20137.","journal-title":"J Pharm Biomed Anal"},{"issue":"8","key":"ref37","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1021\/acschemneuro.9b00305","article-title":"6-Monoacetylmorphine (6-MAM), not morphine, is responsible for the rapid neural effects induced by intravenous heroin","volume":"10","author":"Perekopskiy D","year":"2019","unstructured":"Perekopskiy D, Kiyatkin EA. 6-Monoacetylmorphine (6-MAM), not morphine, is responsible for the rapid neural effects induced by intravenous heroin. ACS Chem Neurosci. 2019;10(8):3409\u201314.","journal-title":"ACS Chem Neurosci"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s002130050956","article-title":"Comparison of intravenous and intranasal heroin self-administration by morphine-maintained humans","volume":"143","author":"Comer SD","year":"1999","unstructured":"Comer SD, Collins ED, MacArthur RB, Fischman MW. Comparison of intravenous and intranasal heroin self-administration by morphine-maintained humans. Psychopharmacology. 1999;143:327\u201338.","journal-title":"Psychopharmacology"},{"issue":"20","key":"ref39","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1113\/JP285163","article-title":"A comparative examination of morphine and fentanyl: unravelling the differential impacts on breathing and airway stability","volume":"601","author":"Burgraff NJ","year":"2023","unstructured":"Burgraff NJ, Baertsch NA, Ramirez JM. A comparative examination of morphine and fentanyl: unravelling the differential impacts on breathing and airway stability. J Physiol. 2023;601(20):4625\u201342.","journal-title":"J Physiol"},{"issue":"17","key":"ref40","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25179314","article-title":"Molecular Sex Differences and Clinical Gender Efficacy in Opioid Use Disorders: From Pain Management to Addiction","volume":"25","author":"Concato M","year":"2024","unstructured":"Concato M, Giacomello E, Al-Habash I, Alempijevic D, Kolev YG, Buffon M, Radaelli D, D'Errico S. Molecular Sex Differences and Clinical Gender Efficacy in Opioid Use Disorders: From Pain Management to Addiction. Int J Mol Sci. 2024;25(17).","journal-title":"Int J Mol Sci"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"104522","DOI":"10.1016\/j.neubiorev.2022.104522","article-title":"Sex differences in opioid receptor mediated effects: role of androgens","volume":"134","author":"Sharp JL","year":"2022","unstructured":"Sharp JL, Pearson T, Smith MA. Sex differences in opioid receptor mediated effects: role of androgens. Neurosci Biobehav Rev. 2022;134:104522.","journal-title":"Neurosci Biobehav Rev"},{"issue":"10","key":"ref42","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10102468","article-title":"Sex Differences in Oxycodone\/Naloxone vs. Tapentadol in Chronic Non-Cancer Pain: An Observational Real-World Study","volume":"10","author":"Barrachina J","year":"2022","unstructured":"Barrachina J, Margarit C, Muriel J, Lopez-Gil V, Lopez-Gil S, Ballester P, Mira-Lorente L, Agullo L, Peiro AM. Sex Differences in Oxycodone\/Naloxone vs. Tapentadol in Chronic Non-Cancer Pain: An Observational Real-World Study. Biomedicines. 2022;10(10).","journal-title":"Biomedicines"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.pbb.2008.05.023","article-title":"Sex and opioid maintenance dose influence response to naloxone in opioid-dependent humans: a retrospective analysis","volume":"90","author":"Chopra MP","year":"2008","unstructured":"Chopra MP, Feldman Z, Mancino MJ, Oliveto A. Sex and opioid maintenance dose influence response to naloxone in opioid-dependent humans: a retrospective analysis. Pharmacol Biochem Behav. 2008;90:787\u201396.","journal-title":"Pharmacol Biochem Behav"},{"issue":"23","key":"ref44","article-title":"Neural basis of opioid-induced respiratory depression and its rescue","volume":"118","author":"Liu S","year":"2021","unstructured":"Liu S et al. Neural basis of opioid-induced respiratory depression and its rescue. Proc Natl Acad Sci U S A. 2021;118(23).","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9228632\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9228632\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T16:08:46Z","timestamp":1794845326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9228632\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":44,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-9228632\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1186\/s40360-026-01282-1","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2026,6,1]]},"subtype":"preprint"}}